We are live on ! Find out more
DGX icon

Quest Diagnostics

558 hedge funds and large institutions have $11.2B invested in Quest Diagnostics in 2016 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 205 increasing their positions, 197 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

61% more call options, than puts

Call options by funds: $37.9M | Put options by funds: $23.6M

27% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 41

22% more funds holding in top 10

Funds holding in top 10: 911 (+2)

21% more capital invested

Capital invested by funds: $9.29B → $11.2B (+$1.95B)

3.82% more ownership

Funds ownership: 93.85%97.66% (+3.8%)

4% more repeat investments, than reductions

Existing positions increased: 205 | Existing positions reduced: 197

0% more funds holding

Funds holding: 557558 (+1)

Holders
558
Holders Change
+1
Holders Change %
+0.18%
% of All Funds
14.89%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.29%
New
52
Increased
205
Reduced
197
Closed
41
Calls
$37.9M
Puts
$23.6M
Net Calls
+$14.3M
Net Calls Change
+$1.29M
Name Holding Trade Value Shares
Change
Change in
Stake
OTPPB
176
Ontario Teachers' Pension Plan Board
Ontario, Canada
$4.35M +$519K +6,817 +15%
CTA
177
Colonial Trust Advisors
South Carolina
$4.31M +$168K +2,211 +4%
CMBA
178
C.M. Bidwell & Associates
Hawaii
$4.29M +$267K +3,510 +7%
BCM
179
BTC Capital Management
Iowa
$4.24M -$50K -656 -1%
Royal London Asset Management
180
Royal London Asset Management
United Kingdom
$4.21M -$188M -2,472,703 -98%
AIMCA
181
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$4.15M
JGUA
182
John G. Ullman & Associates
New York
$4.07M +$3.5K +46 +0.1%
ASRS
183
Arizona State Retirement System
Arizona
$4.06M -$404K -5,300 -10%
TPSF
184
Texas Permanent School Fund
Texas
$3.73M -$257K -3,375 -7%
BNP Paribas Asset Management
185
BNP Paribas Asset Management
France
$3.73M +$383K +5,029 +12%
AAM
186
Aston Asset Management
Illinois
$3.68M -$355K -4,661 -9%
SGH
187
Sivik Global Healthcare
Connecticut
$3.66M +$3.43M +45,000 New
Voloridge Investment Management
188
Voloridge Investment Management
Florida
$3.64M +$3.4M +44,694 New
GIBU
189
Gulf International Bank (UK)
United Kingdom
$3.62M +$83.8K +1,100 +3%
WIC
190
Willis Investment Counsel
Georgia
$3.59M -$6.35M -83,400 -65%
USAA
191
United Services Automobile Association
Texas
$3.57M
PA
192
Pinnacle Associates
New York
$3.42M +$18.1K +238 +0.6%
State of New Jersey Common Pension Fund D
193
State of New Jersey Common Pension Fund D
New Jersey
$3.26M
Los Angeles Capital Management
194
Los Angeles Capital Management
California
$3.22M +$2.03M +26,616 +206%
SB
195
Suntrust Banks
Georgia
$3.2M +$86.5K +1,136 +3%
KBC Group
196
KBC Group
Belgium
$3.18M -$1.42M -18,698 -32%
SO
197
STRS Ohio
Ohio
$3.17M +$34.8K +457 +1%
WRM
198
Weybosset Research & Management
Rhode Island
$3.13M +$211K +2,771 +8%
Comerica Bank
199
Comerica Bank
Texas
$3.06M -$43.9K -576 -2%
EIM
200
ExxonMobil Investment Management
Texas
$2.98M +$141K +1,858 +5%

DGX Hedge Fund Activity: Q2 2016 in Review

558 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2016, worth a combined $11.2B — up 21% from $9.29B a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new DGX positions and 41 closed out — a net gain of 11 holders — while 205 added to existing stakes and 197 trimmed.

The largest buyer was Macquarie Group, adding an estimated $685M. The largest seller was T. Rowe Price Associates, cutting an estimated $229M.

  • 558 institutional investors held Quest Diagnostics (DGX) as of Q2 2016, up from 557 in Q1 2016.
  • Funds reported $11.2B of Quest Diagnostics stock for Q2 2016, up 21% quarter-over-quarter.
  • 52 funds opened new Quest Diagnostics positions in Q2 2016 and 41 closed out, a net change of +11 holders.
  • The largest Quest Diagnostics buyer in Q2 2016 was Macquarie Group, an estimated $685M added.
  • The largest Quest Diagnostics seller in Q2 2016 was T. Rowe Price Associates, an estimated $229M sold.

Based on aggregated 13F filings for Q2 2016.